Venous thromboembolism in multiple myeloma: Increasing evidence in support of direct oral anticoagulants
- 15 August 2023
- journal article
- editorial
- Published by Wiley in British Journal of Haematology
- Vol. 203 (3) , 351-352
Abstract
Venous thromboembolism (VTE) continues to cause significant morbidity and excess mortality in patients with multiple myeloma. The report by Costa and colleagues demonstrates superiority of direct oral anticoagulants over aspirin in terms of VTE prevention, without increased bleeding complications seen.Commentary on: Costa et al. Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta‐analysis. Br J Haematol 2023;203:395–403.Keywords
This publication has 9 references indexed in Scilit:
- Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta‐analysisBritish Journal of Haematology, 2023
- Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN studyBritish Journal of Haematology, 2022
- Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panelHaematologica, 2022
- Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agentsBritish Journal of Haematology, 2020
- Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot studyAmerican Journal of Hematology, 2019
- Venous thromboembolism in multiple myeloma – choice of prophylaxis, role of direct oral anticoagulants and special considerationsBritish Journal of Haematology, 2018
- Thromboprophylaxis in multiple myeloma patients treated with lenalidomide – A systematic reviewThrombosis Research, 2016
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related ComplicationsHaematologica, 2015
- Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaLeukemia, 2007